Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01 per share
-
Shares outstanding
-
144,919,287
-
Total 13F shares
-
126,856,268
-
Share change
-
-1,214,922
-
Total reported value
-
$1,579,633,607
-
Put/Call ratio
-
162%
-
Price per share
-
$12.43
-
Number of holders
-
219
-
Value change
-
-$25,271,746
-
Number of buys
-
112
-
Number of sells
-
120
Institutional Holders of MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI) as of Q2 2023
As of 30 Jun 2023,
MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI) was held by
219 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
126,856,268 shares.
The largest 10 holders included
GTCR LLC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, VANGUARD GROUP INC, Thrivent Financial for Lutherans, BlackRock Inc., MACKENZIE FINANCIAL CORP, 12 West Capital Management LP, Clearbridge Investments, LLC, TWO SIGMA ADVISERS, LP, and Alyeska Investment Group, L.P..
This page lists
219
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.